{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-039422","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2022-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.128678+00:00","generated_at":"2026-06-24T14:47:56.456165+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Director Kuang-Tseng Chen resigns; Yu-Min (Francis) Chung appointed as director","bullets":["Kuang-Tseng Chen resigned from the board on July 10, 2022, for personal reasons, effective immediately.","Yu-Min (Francis) Chung appointed to fill the vacancy on the same day.","Chung was a Partner at Maxpro Ventures (2018-2022) and VP at TaiAn Technology (2016-2018).","Chung holds a Ph.D. in Pharmacy from the University of Iowa and an MBA from National Taiwan University.","Directors receive $3,500 monthly compensation; no family relationships or material interests disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-039422","json":"https://secwatch.observer/filing/0001213900-22-039422.json","markdown":"https://secwatch.observer/filing/0001213900-22-039422.md","text":"https://secwatch.observer/filing/0001213900-22-039422.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390022039422/0001213900-22-039422-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390022039422/ea162775-8k_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T14:47:56.456165+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b753dc822","claim":"Yu-Min (Francis) Chung was appointed as Director at ABVC BIOPHARMA, INC..","evidence_excerpt":"On July 10, 2022, the board of directors (“Board”) of the Company appointed Mr. Yu-Min (Francis) Chung as a director to fill the vacancy resulting from Mr. Chen’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390022039422/0001213900-22-039422-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b5d2c34b07","claim":"Kuang-Tseng Chen resigned as Director at ABVC BIOPHARMA, INC..","evidence_excerpt":"On July 10, 2022, Mr. Kuang-Tseng Chen, a director ABVC BioPharma, Inc. (the “Company”) notified the Company of his resignation from the board of directors for personal reasons, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390022039422/0001213900-22-039422-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}